EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Compensatory Smoking With Very Low Nicotine Content Cigarettes

Rachel L Denlinger-Apte, Ziyu Ji, Emily A Harwood, Darcy Lockhart, Neal L Benowitz, Dana Mowls Carroll, Rachel N Cassidy, Suzanne M Colby, Eric C Donny, Diann E Gaalema, Brandy W Hardy, Dorothy K Hatsukami und 12 weitere

JAMA Network Open · 15.07.2026 · 9 (7) · e2622543

DOI: 10.1001/jamanetworkopen.2026.22543 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JAMA Network Open, online erschienen am 15.07.2026. Verfasst von Rachel L Denlinger-Apte und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health Sciences, Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, North …. Hauptthemen laut MEDLINE: Nicotine, Tobacco Products, Smoking. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The US Food and Drug Administration (FDA) is pursuing a low-nicotine product standard for cigarettes and other combusted tobacco. Very low nicotine content cigarettes (VLNCs) contain approximately 95% less nicotine than standard cigarettes. A key concern is that people who smoke may increase their smoking to compensate for the reduced nicotine levels, which would be a major unintended consequence of the regulation.

Objective

To examine whether people who smoke increase their smoking behavior and/or smoke exposure when smoking VLNCs for extended periods. Data Sources A comprehensive search was performed across multiple databases (eg, PubMed Medline, Embase, Web of Science, Cochrane Library, and CINAHL) on July 5, 2024, to identify randomized clinical trials (RCTs) evaluating VLNCs. Study Selection Eligible RCTs reported treatment conditions comprising smoking VLNCs for 3- to 20-week periods. Control conditions varied but typically included smoking normal nicotine content cigarettes (NNCs). Data Extraction and Synthesis This study followed the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. Two investigators performed the data extraction. Main Outcomes and Measures Outcomes included the total number of cigarettes smoked per day and exhaled breath carbon monoxide (CO) exposure at the end of the intervention.

Results

Seventeen RCTs (16 from the US and 1 from New Zealand) published between 2010 and 2024 met inclusion criteria, representing 5500 adolescents and adults who smoked cigarettes daily or nondaily, with or without quit interest. The pooled meta-analysis included a subset of 2454 participants from 7 US trials. No trials reported increases in the mean number of cigarettes smoked per day or CO exposure at the end of the intervention among participants assigned to VLNCs vs NNCs. It was estimated that 0.8% of participants could expect an increase in smoking, with a maximum expected increase of 3.3 cigarettes smoked per day, and 8.1% could expect an increase in CO exposure, with a maximum expected increase of 4.2 parts per million 6 weeks after randomization if assigned VLNCs vs NNCs. Conclusions and Relevance This systematic review and meta-analysis of VLNC RCTs found minimal evidence of compensation among people assigned to smoke VLNCs. The findings suggest that widespread compensatory smoking is unlikely to occur if the FDA implements a low-nicotine product standard for cigarettes and other combusted tobacco.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NicotineTobacco ProductsSmokingHumansUnited StatesCarbon Monoxide

Substanzen

NicotineCarbon Monoxide

Autor:innen und Institutionen

  • Division of Public Health Sciences, Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis.
  • Department of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Department of Medicine, School of Medicine, University of California, San Francisco.
  • Department of Family Medicine and Community Health, School of Medicine, University of Minnesota, Minneapolis.
  • Center for Alcohol & Addiction Studies, Brown University School of Public Health, Providence, Rhode Island.

Zitieren

APA

Denlinger-Apte, R. L., Ji, Z., Harwood, E. A., Lockhart, D., Benowitz, N. L., Carroll, D. M., Cassidy, R. N., Colby, S. M., Donny, E. C., Gaalema, D. E., Hardy, B. W., Hatsukami, D. K., Heil, S. H., Higgins, S. T., Luo, X., McClernon, F. J., Sigmon, S. C., Smith, T. T., Strasser, A. A., …, & Koopmeiners, J. S. (2026). Compensatory Smoking With Very Low Nicotine Content Cigarettes. JAMA Network Open, 9(7), e2622543. https://doi.org/10.1001/jamanetworkopen.2026.22543

Vancouver

Denlinger-Apte RL, Ji Z, Harwood EA, Lockhart D, Benowitz NL, Carroll DM, et al. Compensatory Smoking With Very Low Nicotine Content Cigarettes. JAMA Network Open. 2026;9(7):e2622543. doi:10.1001/jamanetworkopen.2026.22543

BibTeX
@article{DenlingerApte2026,
  author = {Denlinger-Apte, Rachel L and Ji, Ziyu and Harwood, Emily A and Lockhart, Darcy and Benowitz, Neal L and Carroll, Dana Mowls and Cassidy, Rachel N and Colby, Suzanne M and Donny, Eric C and Gaalema, Diann E and Hardy, Brandy W and Hatsukami, Dorothy K and Heil, Sarah H and Higgins, Stephen T and Luo, Xianghua and McClernon, F Joseph and Sigmon, Stacey C and Smith, Tracy T and Strasser, Andrew A and Tidey, Jennifer W and Vock, David M and White, Cassidy M and Wolf, Jack M and Koopmeiners, Joseph S},
  title = {Compensatory Smoking With Very Low Nicotine Content Cigarettes},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {e2622543},
  doi = {10.1001/jamanetworkopen.2026.22543}
}
Kostenlos starten →